Benson Hill Appoints Ms. Elsner as Interim CEO, Replacing Matt Crisp

June 20, 2023

🌥️Trending News

Benson Hill ($NYSE:BHIL), a leading plant-based technology company based in St. Louis, Missouri, has announced the appointment of Ms. Elsner as the company’s interim chief executive officer, replacing Matt Crisp. Ms. Elsner is an experienced executive with a proven track record of success in technology and business development. She has held various positions in the technology industry, including executive vice president, general manager, and director of strategy. During her tenure, she has led the company’s product and technology initiatives and developed a customer-centric approach to product development.

In addition to her role as interim CEO, Ms. Elsner will also lead Benson Hill’s strategic planning and execution of its long-term vision and mission. The appointment of Ms. Elsner as interim CEO of Benson Hill marks a critical milestone for the company as it seeks to bring its innovative plant-based products to market. With Ms. Elsner at the helm, Benson Hill is well-positioned to continue its success in the plant-based technology market.

Price History

On Friday, Benson Hill announced the appointment of Ms. Elsner as their Interim CEO, replacing Matt Crisp. This news sent shockwaves through the stock market, and the stock opened at $1.2 before closing at $1.0 – a plunge of 13.4% from the previous closing price of $1.2. The drastic decline was a clear indication of investor apprehension towards the change in leadership. Though it is not yet known what plans Ms. Elsner has for the company, it is clear that the transition of power has left investors feeling uncertain. Live Quote…

About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for Benson Hill. More…

    Total Revenues Net Income Net Margin
    449.75 -114.38 -24.6%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for Benson Hill. More…

    Operations Investing Financing
    -77.9 10.36 4.61
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for Benson Hill. More…

    Total Assets Total Liabilities Book Value Per Share
    448.91 254.28 0.94
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for Benson Hill are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    68.6% -14.6%
    FCF Margin ROE ROA
    -20.8% -21.1% -9.1%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items
  • Analysis

    We at GoodWhale recently conducted an analysis of BENSON HILL‘s fundamentals. Our Star Chart shows that BENSON HILL is strong in asset and growth, but weak in dividend and profitability. Based on these results, we classify BENSON HILL as a ‘cheetah’, a type of company that has achieved high revenue or earnings growth but is considered less stable due to lower profitability. Given its classification and mixed fundamentals, we believe that investors looking for high-growth stocks would be interested in BENSON HILL. However, investors should also be aware that BENSON HILL has an intermediate health score of 4/10 with regard to its cashflows and debt, which may make it less able to sustain future operations in times of crisis. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis




  • Peers

    The company’s products include plant-based proteins, oils, and flours. Benson Hill‘s competitors include Arcadia Biosciences Inc, Yield10 Bioscience Inc, Vikas Proppant & Granite Ltd, and other companies that produce plant-based food and ingredients.

    – Arcadia Biosciences Inc ($NASDAQ:RKDA)

    Arcadia Biosciences Inc is a publicly traded company with a market cap of 8.35M as of 2022. The company has a Return on Equity of -27.94%. Arcadia Biosciences is a biotechnology company that focuses on improving the quality and nutritional value of crops. The company uses its proprietary technologies to develop and commercialize products that improve crop yield, reduce pesticide use, and improve human health.

    – Yield10 Bioscience Inc ($NASDAQ:YTEN)

    Bioscience Inc is a company that focuses on providing innovative and sustainable solutions for the food and beverage industry. They have a market cap of 11.94M as of 2022 and a Return on Equity of -68.22%. The company has been facing some financial difficulties recently, but they are still working hard to provide the best possible products and services for their customers.

    – Vikas Proppant & Granite Ltd ($BSE:531518)

    Vikas Proppant & Granite Ltd, a mid-sized company in the mining industry, has a market capitalization of 416.89 million as of 2022. The company’s return on equity is -1.48%. The company’s primary business is the extraction and processing of minerals, including proppants and granite. The company has a strong presence in India and also has operations in other countries, including the United States, China, and Australia. Vikas Proppant & Granite Ltd has a diversified product portfolio and a experienced management team. The company is well-positioned to capitalize on the growing demand for minerals globally.

    Summary

    Benson Hill, a leading technology-driven crop improvement company, recently made a move to appoint Ms. Elsner as interim CEO to replace Matt Crisp. Following the announcement, Benson Hill’s stock price experienced a dip on the same day, causing investors to question the decision. Analysis of the stock shows that it is currently trading significantly lower than its 3-month average price.

    While Benson Hill’s long-term prospects remain uncertain, there is potential for a quick recovery for investors with a risk-taking attitude. Analysts, however, have cautioned against investing in Benson Hill over the short-term due to potential near-term risks and volatility in the market.

    Recent Posts

    Leave a Comment